Production of serum antibodies in response to vaccination against infectious bovine rhinotracheitis and bovine viral diarrhea viruses with a commercial vaccine

The objective was to determine the prevalence of serum antibodies (PSA) in response to vaccination against infectious bovine rhinotracheitis (IBR) and bovine viral diarrhea (BVD) viruses in dairy cows under subtropical conditions. A commercial polyvalent vaccine with inactivated BVD virus and modified active viruses of IBR, parainfluenza 3 and bovine respiratory syndrome was used. Two groups were formed: vaccinated (VEG) and unvaccinated (UEG) experimental group, which were homogeneous in PSA against IBR and BVD before vaccination. VEG was immunized on d 0 and d 30 after the first vaccination (booster vaccine). To detect antibodies, serum samples were collected 30 d after the first and second vaccinations. Serum antibodies against IBR and BVD were determined by the ELISA test. The average PSA against IBR and BVD before vaccination was 16 (18 % in VEG vs 14 % in UEG; P>0.05) and 8 % (10 % in VEG vs 6 % in UEG; P>0.05), respectively. The first and second vaccinations against IBR induced the formation of antibodies 30 d after their application; with the first vaccination, PSA in vaccinated cows was 36 percentage units higher (P<0.05) than in unvaccinated cows (58 vs 22 %) and with the booster vaccine, PSA in vaccinated cows was 66 percentage units higher (P<0.05) than in unvaccinated cows (94 vs 28 %). The commercial vaccine did not induce the production of antibodies against BVD with either immunization.

Saved in:
Bibliographic Details
Main Authors: Rosete Fernández, Jorge Víctor, Socci Escatell, Guadalupe Asunción, Fragoso Islas, Abraham, Olazarán Jenkins, Sara, Ríos Utrera, Ángel
Format: Digital revista
Language:spa
eng
Published: Instituto Nacional de Investigaciones Forestales, Agrícolas y Pecuarias 2023
Online Access:https://cienciaspecuarias.inifap.gob.mx/index.php/Pecuarias/article/view/5657
Tags: Add Tag
No Tags, Be the first to tag this record!
id rev-remexcp-article5657
record_format ojs
institution INIFAP
collection OJS
country México
countrycode MX
component Revista
access En linea
databasecode rev-remexcp
tag revista
region America del Norte
libraryname Biblioteca INIFAP
language spa
eng
format Digital
author Rosete Fernández, Jorge Víctor
Socci Escatell, Guadalupe Asunción
Fragoso Islas, Abraham
Olazarán Jenkins, Sara
Ríos Utrera, Ángel
spellingShingle Rosete Fernández, Jorge Víctor
Socci Escatell, Guadalupe Asunción
Fragoso Islas, Abraham
Olazarán Jenkins, Sara
Ríos Utrera, Ángel
Production of serum antibodies in response to vaccination against infectious bovine rhinotracheitis and bovine viral diarrhea viruses with a commercial vaccine
author_facet Rosete Fernández, Jorge Víctor
Socci Escatell, Guadalupe Asunción
Fragoso Islas, Abraham
Olazarán Jenkins, Sara
Ríos Utrera, Ángel
author_sort Rosete Fernández, Jorge Víctor
title Production of serum antibodies in response to vaccination against infectious bovine rhinotracheitis and bovine viral diarrhea viruses with a commercial vaccine
title_short Production of serum antibodies in response to vaccination against infectious bovine rhinotracheitis and bovine viral diarrhea viruses with a commercial vaccine
title_full Production of serum antibodies in response to vaccination against infectious bovine rhinotracheitis and bovine viral diarrhea viruses with a commercial vaccine
title_fullStr Production of serum antibodies in response to vaccination against infectious bovine rhinotracheitis and bovine viral diarrhea viruses with a commercial vaccine
title_full_unstemmed Production of serum antibodies in response to vaccination against infectious bovine rhinotracheitis and bovine viral diarrhea viruses with a commercial vaccine
title_sort production of serum antibodies in response to vaccination against infectious bovine rhinotracheitis and bovine viral diarrhea viruses with a commercial vaccine
description The objective was to determine the prevalence of serum antibodies (PSA) in response to vaccination against infectious bovine rhinotracheitis (IBR) and bovine viral diarrhea (BVD) viruses in dairy cows under subtropical conditions. A commercial polyvalent vaccine with inactivated BVD virus and modified active viruses of IBR, parainfluenza 3 and bovine respiratory syndrome was used. Two groups were formed: vaccinated (VEG) and unvaccinated (UEG) experimental group, which were homogeneous in PSA against IBR and BVD before vaccination. VEG was immunized on d 0 and d 30 after the first vaccination (booster vaccine). To detect antibodies, serum samples were collected 30 d after the first and second vaccinations. Serum antibodies against IBR and BVD were determined by the ELISA test. The average PSA against IBR and BVD before vaccination was 16 (18 % in VEG vs 14 % in UEG; P>0.05) and 8 % (10 % in VEG vs 6 % in UEG; P>0.05), respectively. The first and second vaccinations against IBR induced the formation of antibodies 30 d after their application; with the first vaccination, PSA in vaccinated cows was 36 percentage units higher (P<0.05) than in unvaccinated cows (58 vs 22 %) and with the booster vaccine, PSA in vaccinated cows was 66 percentage units higher (P<0.05) than in unvaccinated cows (94 vs 28 %). The commercial vaccine did not induce the production of antibodies against BVD with either immunization.
publisher Instituto Nacional de Investigaciones Forestales, Agrícolas y Pecuarias
publishDate 2023
url https://cienciaspecuarias.inifap.gob.mx/index.php/Pecuarias/article/view/5657
work_keys_str_mv AT rosetefernandezjorgevictor productionofserumantibodiesinresponsetovaccinationagainstinfectiousbovinerhinotracheitisandbovineviraldiarrheaviruseswithacommercialvaccine
AT socciescatellguadalupeasuncion productionofserumantibodiesinresponsetovaccinationagainstinfectiousbovinerhinotracheitisandbovineviraldiarrheaviruseswithacommercialvaccine
AT fragosoislasabraham productionofserumantibodiesinresponsetovaccinationagainstinfectiousbovinerhinotracheitisandbovineviraldiarrheaviruseswithacommercialvaccine
AT olazaranjenkinssara productionofserumantibodiesinresponsetovaccinationagainstinfectiousbovinerhinotracheitisandbovineviraldiarrheaviruseswithacommercialvaccine
AT riosutreraangel productionofserumantibodiesinresponsetovaccinationagainstinfectiousbovinerhinotracheitisandbovineviraldiarrheaviruseswithacommercialvaccine
AT rosetefernandezjorgevictor producciondeanticuerpossericosenrespuestaalavacunacioncontralosvirusdelarinotraqueitisinfecciosabovinayladiarreaviralbovinaconunavacunacomercial
AT socciescatellguadalupeasuncion producciondeanticuerpossericosenrespuestaalavacunacioncontralosvirusdelarinotraqueitisinfecciosabovinayladiarreaviralbovinaconunavacunacomercial
AT fragosoislasabraham producciondeanticuerpossericosenrespuestaalavacunacioncontralosvirusdelarinotraqueitisinfecciosabovinayladiarreaviralbovinaconunavacunacomercial
AT olazaranjenkinssara producciondeanticuerpossericosenrespuestaalavacunacioncontralosvirusdelarinotraqueitisinfecciosabovinayladiarreaviralbovinaconunavacunacomercial
AT riosutreraangel producciondeanticuerpossericosenrespuestaalavacunacioncontralosvirusdelarinotraqueitisinfecciosabovinayladiarreaviralbovinaconunavacunacomercial
_version_ 1762928179360563200
spelling rev-remexcp-article56572023-04-03T19:17:36Z Production of serum antibodies in response to vaccination against infectious bovine rhinotracheitis and bovine viral diarrhea viruses with a commercial vaccine Producción de anticuerpos séricos en respuesta a la vacunación contra los virus de la rinotraqueitis infecciosa bovina y la diarrea viral bovina con una vacuna comercial Rosete Fernández, Jorge Víctor Socci Escatell, Guadalupe Asunción Fragoso Islas, Abraham Olazarán Jenkins, Sara Ríos Utrera, Ángel Infectious bovine rhinotracheitis; Bovine viral diarrhea; Polyvalent vaccine; Modified active virus; Inactivated virus; Serum antibodies; Dairy cows Rinotraqueitis infecciosa bovina; Diarrea viral bovina; Vacuna polivalente; Virus activo modificado; Virus inactivado; Anticuerpos séricos; Vacas lecheras The objective was to determine the prevalence of serum antibodies (PSA) in response to vaccination against infectious bovine rhinotracheitis (IBR) and bovine viral diarrhea (BVD) viruses in dairy cows under subtropical conditions. A commercial polyvalent vaccine with inactivated BVD virus and modified active viruses of IBR, parainfluenza 3 and bovine respiratory syndrome was used. Two groups were formed: vaccinated (VEG) and unvaccinated (UEG) experimental group, which were homogeneous in PSA against IBR and BVD before vaccination. VEG was immunized on d 0 and d 30 after the first vaccination (booster vaccine). To detect antibodies, serum samples were collected 30 d after the first and second vaccinations. Serum antibodies against IBR and BVD were determined by the ELISA test. The average PSA against IBR and BVD before vaccination was 16 (18 % in VEG vs 14 % in UEG; P>0.05) and 8 % (10 % in VEG vs 6 % in UEG; P>0.05), respectively. The first and second vaccinations against IBR induced the formation of antibodies 30 d after their application; with the first vaccination, PSA in vaccinated cows was 36 percentage units higher (P<0.05) than in unvaccinated cows (58 vs 22 %) and with the booster vaccine, PSA in vaccinated cows was 66 percentage units higher (P<0.05) than in unvaccinated cows (94 vs 28 %). The commercial vaccine did not induce the production of antibodies against BVD with either immunization. El objetivo fue determinar la prevalencia de anticuerpos séricos (PAS) en respuesta a la vacunación contra los virus de la rinotraqueitis infecciosa bovina (RIB) y diarrea viral bovina (DVB) en vacas lecheras en condiciones subtropicales. Se utilizó una vacuna polivalente comercial con virus inactivado de la DVB y virus activos modificados de la RIB, parainfluenza 3 y síndrome respiratorio bovino. Se formaron dos grupos: grupo experimental vacunado (GEV) y no vacunado (GEN), que fueron homogéneos en PAS contra RIB y DVB antes de la vacunación. El GEV se inmunizó el día 0 y el día 30 después de la primera vacunación (vacuna de refuerzo). Para detectar anticuerpos, se obtuvieron muestras de suero 30 días después de la primera y segunda vacunación. Los anticuerpos séricos contra RIB y DVB se determinaron mediante la prueba de ELISA. La PAS promedio contra RIB y DVB antes de la vacunación fue 16 (18 % en el GEV vs 14 % en el GEN; P>0.05) y 8 % (10 % en el GEV vs 6 % en el GEN; P>0.05), respectivamente. La primera y segunda vacunación contra RIB indujeron la formación de anticuerpos 30 días después de su aplicación; con la primera vacunación, la PAS en las vacas vacunadas fue 36 unidades porcentuales mayor (P<0.05) que en las no vacunadas (58 vs 22 %) y con la vacuna de refuerzo, la PAS en las vacas vacunadas fue 66 unidades porcentuales mayor (P<0.05) que en las no vacunadas (94 vs 28 %). La vacuna comercial no indujo la producción de anticuerpos contra DVB con ninguna de las dos inmunizaciones. Instituto Nacional de Investigaciones Forestales, Agrícolas y Pecuarias INIFAP 2023-04-03 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion application/pdf application/pdf text/html https://cienciaspecuarias.inifap.gob.mx/index.php/Pecuarias/article/view/5657 10.22319/rmcp.v14i2.5657 Revista Mexicana de Ciencias Pecuarias; Vol. 14, Núm. 2 (2023): Abril-Junio; 260-276 Revista Mexicana de Ciencias Pecuarias; Vol. 14, Núm. 2 (2023): Abril-Junio; 260-276 2448-6698 2007-1124 spa eng https://cienciaspecuarias.inifap.gob.mx/index.php/Pecuarias/article/view/5657/4890 https://cienciaspecuarias.inifap.gob.mx/index.php/Pecuarias/article/view/5657/4891 https://cienciaspecuarias.inifap.gob.mx/index.php/Pecuarias/article/view/5657/5124 http://creativecommons.org/licenses/by-nc-sa/4.0